Ignite Creation Date:
2024-05-06 @ 4:04 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04868708
Status:
COMPLETED
Last Update Posted:
2024-04-25
First Post:
2021-04-05
Brief Title:
A Study of AK104 an Anti-PD-1 and Anti-CTLA-4 Bispecific Antibody in Recurrent or Metastatic Cervical Cancer
Sponsor:
Akeso
Organization:
Akeso
Organization Data
Organization:
Akeso
Class:
INDUSTRY
Study ID:
AK104-210
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Akeso
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None